The trademark application ANAPHYLM was filed by Aquestive Therapeutics, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on August 11, 2022, and it was registered by office on November 18, 2022 without any oppositions.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 5 with Pharmaceutical preparations for the treatment or prevention of allergic reaction, anaphylaxis, and asthma and pharmaceutical preparations containing epinephrine or prodrugs of epinephrine for the treatment or prevention of anaphylaxis, asthma, and allergic reactions..